F3 and breast cancer: Of note, the identification of CD142 (also known as tissue factor) as an antigen highly expressed in TNBC cells and CSCs, led to development of CAR-NKs specific for this aggressive type of BC, which led to positive results in preclinical studies (190), and similar results were obtained with EGFR-CAR NK cells (191), opening the way for a clinical development.